- Home
- TARA vs AMWL Comparison
TARA vs AMWL Comparison
Compare TARA & AMWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- AMWL
- Stock Information
- Founded
- TARA N/A
- AMWL 2006
- Country
- TARA United States
- AMWL United States
- Employees
- TARA N/A
- AMWL N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- AMWL Retail: Computer Software & Peripheral Equipment
- Sector
- TARA Health Care
- AMWL Technology
- Exchange
- TARA Nasdaq
- AMWL Nasdaq
- Market Cap
- TARA 158.2M
- AMWL 165.1M
- IPO Year
- TARA N/A
- AMWL 2020
- Fundamental
- Price
- TARA $3.72
- AMWL $11.74
- Analyst Decision
- TARA Strong Buy
- AMWL Hold
- Analyst Count
- TARA 3
- AMWL 6
- Target Price
- TARA $22.67
- AMWL $11.90
- AVG Volume (30 Days)
- TARA 270.4K
- AMWL 93.2K
- Earning Date
- TARA 03-12-2025
- AMWL 02-12-2025
- Dividend Yield
- TARA N/A
- AMWL N/A
- EPS Growth
- TARA N/A
- AMWL N/A
- EPS
- TARA N/A
- AMWL N/A
- Revenue
- TARA N/A
- AMWL $254,364,000.00
- Revenue This Year
- TARA N/A
- AMWL $9.66
- Revenue Next Year
- TARA N/A
- AMWL $7.53
- P/E Ratio
- TARA N/A
- AMWL N/A
- Revenue Growth
- TARA N/A
- AMWL N/A
- 52 Week Low
- TARA $1.60
- AMWL $5.00
- 52 Week High
- TARA $10.48
- AMWL $22.60
- Technical
- Relative Strength Index (RSI)
- TARA 33.05
- AMWL 57.59
- Support Level
- TARA $3.91
- AMWL $11.18
- Resistance Level
- TARA $4.05
- AMWL $12.95
- Average True Range (ATR)
- TARA 0.29
- AMWL 0.81
- MACD
- TARA -0.07
- AMWL -0.04
- Stochastic Oscillator
- TARA 0.00
- AMWL 57.90
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About AMWL American Well Corporation
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.